JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Issues journals
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 6
DOI:10.33266/1024-6177-2023-68-6-60-66
A.R. Tukov, I.L. Shafransky, O.N. Prokhorova, A.M. Mikhailenko, M.N. Ziyatdinov
Diabetes Mellitus Incidence and the Risk of its Occurrence in Liquidators of the Chnpp Accident Consequences including Nuclear Industry Workers
A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: A.R. Tukov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Summary: Investigation purposes Diabetes mellitus (DM) occupies the largest share in the structure of endocrine system diseases, nutritional disorders and metabolic disorders, which is currently one of the important priorities of national health systems. Research on certain groups of the population with their own harmful occupational risk factors is relevant. Analysis of the incidence of diabetes mellitus of the second type - T2DM (ICD 10: E11-E11.9) of liquidators of the consequences of the Chernobyl accident ‒ workers of nuclear industry enterprises for 30 years of observation and assessment of the radiation risk of its occurrence.
Material and methods: The study includes data from the Industry register of persons exposed to radiation as a result of the Chernobyl accident over a thirty-year period, having a verified dose of external radiation received during work in the 30 km zone of the Chernobyl nuclear power plant, men – 12663 people, 1327, of whom have data on the dose of occupational irradiation. The Poisson process with an intensity parameter was chosen as a statistical model of morbidity.
Results: The incidence of T2DM in liquidators of the consequences of the Chernobyl accident was estimated by age and sex groups. On the basis of the obtained file of individual unstratified data, an analytical likelihood function for the Poisson process was constructed and the value of the excess relative risk (ERR) of T2DM incidence was calculated and the nature of the dose dependence of RR was investigated.
A cohort epidemiological study of a group of liquidators in 1986–1990 was carried out. over a thirty-year period, depending on the dose, both received during the liquidation of the consequences of the Chernobyl accident, and during professional work with radioactive substances (RS) and sources of ionizing radiation (IRS). Direct estimates of the radiogenic risk of diabetes mellitus are given. Different values of risk were noted when using doses from different types of radiation. There was no significant increase in the risk of disease per dose unit (ERR / Sv).
Conclusion: With the aging of the cohort of liquidators, an increase in the incidence of T2DM was noted in both men and women. The results obtained on the assessment of the radiation risk of T2DM at this stage are taken as preliminary, since the use of radiation risk in the development of radiation safety regulations requires a total dose from all types of exposure (professional, emergency, medical, natural).
Keywords: diabetes, incidence, radiation, relative risk, overweight, Chernobyl accident, employees of the nuclear industry, sectoral register
For citation: Tukov AR, Shafransky IL, Prokhorova ON, Mikhailenko AM, Ziyatdinov MN. Diabetes Mellitus Incidence and the Risk of its Occurrence in Liquidators of the Chnpp Accident Consequences including Nuclear Industry Workers. Medical Radiology and Radiation Safety. 2023;68(6):60–66. (In Russian). DOI:10.33266/1024-6177-2023-68-6-60-66
References
1. Dedov I.I. Diabetes Mellitus – the Most Dangerous Challenge to the World Community. Vestnik Rossiiskoy Akademii Meditsinskikh Nauk = Annals of the Russian Academy of Medical Sciences. 2012;1:7-13 (In Russ.).
2. Dedov I.I., Shestakova M.V., Suntsov Yu.I., et al. Federal Targeted Programme ‘Prevention and Management of Socially Significant Diseases (2007-2012)’: Results of the ‘Diabetes Mellitus’ Sub-Programme. Sakharnyy Diabet = Diabetes Mellitus. 2013;16;2S:2-48 (In Russ.).
3. IDF Diabetes Atlas. Brussels, Belgium, International Diabetes Federation, 2015. URL: http://www.diabetesatlas.org/.
4. Maslova OV., Suntsov Yu.I. Epidemiology of Diabetes Mellitus and Microvascular Complications. Sakharnyy Diabet = Diabetes Mellitus. 2011;3:6-12 (In Russ.).
5. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care. 2013;36;4:1033–1046.
6. Dedov I.I. Algorithms of Specialized Medical Care Patients with Diabetes. Ed. Dedov I.I., Shestakova M.V. Moscow Publ., 2015. P. 7-112 (In Russ.).
7. Vologodskaya I.A., Fomin E.A., Kovin A.I. Improving the Medical Monitoring System for Employees of the Nuclear Industry Enterprises. Meditsina: Tselevyye Proyekty. 2014;19:35-37 (In Russ.).
8. Vologodskaya I.A., Kurbatov A.V., Grigor’eva E.S. Predisposition to Multifactorial Pathology in Residents of the City in the Zone Around the “Maiak” Atomic Industry Enterprise. Radiats. Biol. Radioecol. 2002;42;6:690-692.
9. Pishhugina A.V., Ivanov A.G., Belyakova N.A. Features of the Incidence of Nuclear Energy Operating at the Enterprise. Problemy Sotsialnoy Gigiyeny, Zdravookhraneniya i Istorii Meditsiny = Problems of Social Hygiene, Public Health and History of Medicine. 2013;1:18-21 (In Russ.).
10. Florent de Vathaire, Chiraz El-Fayech, Faten Fedhila Ben Ayed, et. al. Radiation Dose to the Pancreas and Risk of Diabetes Mellitus in Childhood Cancer Survivors: a Retrospective Cohort Study. Lancet Oncol. 2012;13;10:1002-1010. doi: 10.1016/S1470-2045(12)70323-6.
11. A van Nimwegen F., Schaapveld M., Janus C.P.M., et. al. Risk of Diabetes Mellitus in Long-Term Survivors of Hodgkin Lymphoma. J. Clin. Oncol. 2014;32;29б:3257-3263. doi: 10.1200/JCO.2013.54.4379.
12. Meacham L.R., Sklar C.A., Li S., et. al. Diabetes Mellitus in long-term Survivors of Childhood Cancer. Increased Risk Associated with Radiation Therapy: a Report for the Childhood Cancer Survivor Study. Arch. Intern. Med. 2009;169;15:1381-1388. doi: 10.1001/archinternmed. 2009. 209.
13. Breslow N.E., Day N.E. Statistical Methods in Cancer Research. V. I. The Analysis of Case-Control Studies. IARC Scientific Publication No. 32. Lyon, IARC, 1980.
14. Preston D.L., Lubin D.B., Pierce D.A., McConney M.E. Epicure Users Guide. Seattle, WA, Hirosoft Inter-National Corporation, 1993. 330 p.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The work was carried out as part of the implementation of the State Order.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2023. Accepted for publication: 27.08.2023.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 6
DOI:10.33266/1024-6177-2023-68-6-67-72
Zh.V. Sheikh1, 2, 3, 4, S.N. Shvayko2, L.G. Leonova2, E.V. Tarachkova1,
E.I. Bogdanova1, E.S. Stepanchenko1
Cryptogenic Organizing Pneumonia (Clinical Case Report, Literature Review)
1 Russian Medical Academy of Continuing Professional Education, Moscow, Russia
2 S.P. Botkin City Clinical Hospital, Moscow, Russia
3 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
4 P. Lumumba Russian Peoples̕ Frendship University, Moscow, Russia
Contact person: Zh.V. Sheikh, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Summary
Despite the widespread introduction of CT into clinical practice, the diagnosis of cryptogenic organizing pneumonia is still an urgent task of modern radiology. Radiological diagnosticians and clinicians have significant difficulties in diagnosis due to rather low frequency of this disease and nonspecific clinical manifestations. Cryptogenic organizing pneumonia is a disease which sharply worsens the quality of life in case of untimely diagnosis and belongs to the group of idiopathic interstitial pneumonias. The article is devoted to the clinical case of a patient with verified cryptogenic organizing pneumonia. CT of the chest organs, along with clinical data, plays a key role in the accurate diagnosis of organizing pneumonia.
Keywords: cryptogenic organizing pneumonia, organizing pneumonia, idiopathic interstitial pneumonia, computed tomography, “frosted glass”
For citation: Sheikh ZhV, Shvayko SN, Leonova LG, Tarachkova EV, Bogdanova EI, Stepanchenko ES. Cryptogenic Organizing Pneumonia (Clinical Case Report, Literature Review). Medical Radiology and Radiation Safety. 2023;68(6):67–72. (In Russian). DOI:10.33266/1024-6177-2023-68-6-67-72
References
1. Avdeyev S.N. Intensivnaya Terapiya v Pulmonologii = Intensive Therapy in Pulmonology. V.2. Moscow Publ., 2015. P. 116, 121 (In Russ.).
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was Adopted by the ATS Board of Directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002;165;2:277–304.
3. Cushley M.J., Davison A.G., du Bois R.M., et al. The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults. Thorax. 1999;54:S1–S30.
4. Baque-Juston M., Pellegrin A., Leroy S., Marquette C.H., Padovani B. Organizing Pneumonia: what Is it? A Conceptual Approach and Pictorial. Diagn. Interv. Imaging. 2014;95;9:771–777.
5. Joyce Lee, MD, MAS, University of Colorado School of Medicine. MSD Handbook (Interstitial Lung Disease).
6. Ilkovich M.M. Interstitial Lung Diseases: Reasoning on a Topical Issue. Part 1. Consilium Medicum. 2014;1:4-7 (In Russ.).
7. Karnaushkina M.A., Averyanov A.V., Lesnyak V.N. The “Frosted Glass” Syndrome in the Evaluation of CT Images of Thoracic Organs in the Practice of the Clinician: Pathogenesis, Significance, Differential Diagnosis. Arkhiv Vnutrenney Meditsiny = The Russian Archives of Internal Medicine. 2018;8;3:165-175 (In Russ.).
8. Wells A.U., Hirani N. Interstitial Lung Disease Guideline: the British Thoracic Society in Collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63;5:v1-58. doi: 10.1136/thx.2008.101691.
9. Avdeyev S.N., et al. Atmosfera. Pulmonologiya i Allergologiya. 2011 (In Russ.).
10. Chernyayev A.L., Samsonova M.V. Diagnosis of Idiopathic Interstitial Pneumonia. Uralskiy Meditsinskiy Zhurnal = Ural Medical Journal. 2017;4:5-8 (In Russ.).
11. Lenshin A.V., Perelman V.M., Ilin A.V., Karapetyan E.I., Maltseva T.A. Byulleten Fiziologii i Patologii Dykhaniya = Bulletin of Physiology and Pathology of Respiration. 2016;60
(In Russ.).
12. Cherian S.V., Patel D., Machnicki S., Naidich D., et al. Algorithmic Approach to the Diagnosis of Organizing Pneumonia: A Correlation of Clinical, Radiologic, and Pathologic Features. Chest. 2022;162;1:156-178. doi: 10.1016/j.chest.2021.12.659.
13. Avdeyev S.N., Chernyayev A.L. Orotting Pneumonia. Atmosfera. Pulmonologiya i Allergologiya. 2011;1:6-13 (In Russ.).
14. Sheikh Zh.V., Nudnov N.V., Karmazanovskiy G.G., et al. Sistemnyye Vaskulity: Vozmozhnosti Sovremennoy Meditsinskoy Vizualizatsii = Systemic Vasculitis: the Possibilities of Moder Medical Imaging. Moscow Publ., 2019. P. 42-45 (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2023. Accepted for publication: 27.08.2023.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 6
DOI:10.33266/1024-6177-2023-68-6-80-85
S.N. Prokhorov1, N.V. Kochergina1, 2, A.D. Ryzhkov1, 2,A.S. Krylov1, A.B. Bludov1
The Apparent Diffusion Coefficient in the Diagnosis of Metastatic Lesions of Skeletal Bones
1 N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia
2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia
Contact person: Sergei Nikolaevich Prokhorov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Aim: To evaluate the possibilities of absolute and relative values of the apparent diffusion coefficient (ADC) in the diagnosis of metastatic lesions of skeletal bones.
Material and methods: The study included 12 patients with metastatic bone lesions, before any treatment was applied. The age of the patients ranged from 38 to 73 years, 3 men, 9 women. Among the morphological forms of tumors were presented: cancers of the breast (3), prostate (1) glands, colon (1), lung (2), body (1) and cervix (1) uterus, thyroid (1) and pancreas (2). The detected changes were classified on the basis of Bone scan, SPECT/CT and standard MRI. The ADC values of unchanged bone marrow (n=360), divided by anatomical zones, metastatic foci (n=117), as well as benign changes of various nature (n=19) were analyzed. The ratio of the ADC values of each of the metastatic and benign focal formations to the normal values for each of the localizations was calculated.
Results: Unchanged bone marrow, depending on anatomical localization (cervical, thoracic, lumbar spine, pelvic bones, shoulder blades, collarbones, sternum, ribs, proximal humerus and femur bones) from the point of view of ADC, showed statistically significant heterogeneity. Statistical analysis has shown that there is no connection between the groups of ADC indicators in the foci of metastatic lesions, combined depending on the anatomical localization. With a similar comparison, but by belonging to the primary tumor, an even greater intergroup difference was found. ADC values in the foci of metastatic lesions turned out to be dependent on the morphological type of the primary tumor and significantly differ both from metastases of other morphological affiliation and from normal red bone marrow parameters. The use of relative values allowed to increase the specificity from 15 to 19 %.
Conclusion: This study showed that knowledge of the range of reference ADC values for unchanged red bone marrow and anomalies of various genesis is important in differential diagnosis. The differentiation of the skeleton into separate anatomical zones probably makes it possible to increase the effectiveness of the isolated application of the technique when it comes to absolute values. The morphological affiliation of metastatic foci is important in the formation of ADC values, rather than the bone marrow microenvironment, which is also supported by the low efficiency of the use of relative values.
Keywords: bone metastases, MRI, apparent diffusion coefficient, SPECT/CT, bone scan
For citation: Prokhorov SN, Kochergina NV, Ryzhkov AD, Krylov AS, Bludov AB. The Apparent Diffusion Coefficient in the Diagnosis of Metastatic Lesions of Skeletal Bones. Medical Radiology and Radiation Safety. 2023;68(6):80–85. (In Russian). DOI:10.33266/1024-6177-2023-68-6-80-85
References
1. Coleman R.E. Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity. Clin Cancer Res. 2006;12;20:6243–6269.
2. Davila D., Antoniou A., Chaudhry M.A. Evaluation of Osseous Metastasis in Bone Scintigraphy. Semin. Nucl. Med. 2015;45;1:3-15.
3. Umer M., et al. Skeletal Metastasis in Renal Cell Carcinoma: a Review. Ann. Med. Surg. (Lond). 2018;27:9–16.
4. Hagiwara M., et al. The Impact of Bone Metastases and Skeletal-Related Events on Healthcare Costs in Prostate Cancer Patients Receiving Hormonal Therapy. Community Oncol. 2011;11;8:508–515.
5. Barlev A. Payer Costs for Inpatient Treatment of Pathologic Fracture, Surgery to Bone, and Spinal Cord Compression among Patients with Multiple Myeloma or Bone Metastasis Secondary to Prostate or Breast Cancer. J. Manag. Care Pharm. 2010;16;9:693–702.
6. Cook G.J., Houston S., Rubens R., Maisey M.N., Fogelman I. Detection of Bone Metastases in Breast Cancer by 18FDG PET: Differing Metabolic Activity in Osteoblastic and osteolytic Lesions. J. Clin. Oncol. 1998;16;10:3375-3379.
7. Кочергина Н.В., Прохоров С.Н., Блудов А.Б., Рыжков А.Д., Федорова А.В., Спирина О.Г. Эффективность МРТ в уточнении наличия метастазов в кости при спорном результате ОФЭКТ/КТ // Онкологический журнал: лучевая диагностика, лучевая терапия. 2020. Т.3, № 3. С. 93-100. [Kochergina N.V., Prokhorov S.N., Bludov A.B., Ryzhkov A.D., Fedorova A.V., Spirina O.G. The Effectiveness of MRI in Determining the Presence of Bone Metastases in a Controversial Result of SPECT/CT. Onkologicheskiy Zhurnal: Luchevaya Diagnostika, Luchevaya Terapiya = Journal of Oncology: Diagnostic Radiology and Radiotherapy. 2020;3;3:93-100
(In Russ.)].
8. Сергеев Н.И. Мультипараметрическая МРТ в диагностике метастатического поражения костных структур // Вестник Российского научного центра рентгенорадиологии Минздрава России. 2015. Т.15, № 1. [Sergeyev N.I. Multiparametric MRI in the Diagnosis of Metastatic Lesion of Bone Structures. Vestnik Rossiyskogo nauchnogo tsentra Rentgenoradiologii MZ Rossii. 2015;15;1 (In Russ.)].
9. Прохоров С.Н., Кочергина Н.В., Рыжков А.Д., Крылов А.С., Блудов А.Б. Сравнение эффективности остеосцинтиграфии, рентгенографии, ОФЭКТ/КТ и МРТ в диагностике метастазов солидных опухолей различной природы в костях // Медицинская радиология и радиационная безопасность. 2022. Т.67, № 6. С. 74-78. [Prokhorov S.N., Kochergina N.V., Ryzhkov A.D., Krylov A.S., Bludov A.B. Сomparison of Bone Scan, X-RAY, SPECT/CT and MRI in the Diagnosis of Bone Metastases in Solid Tumors. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2022;67;6:74-78 (In Russ.)].
10. Nakanishi K., Tanaka J., Nakaya Y., Maeda N., Sakamoto A., Nakayama A., Satomura H., Sakai M., Konishi K., Yamamoto Y., Nagahara A., Nishimura K., Takenaka S., Tomiyama N. Whole-Body MRI: Detecting Bone Metastases from Prostate Cancer. Jpn. J. Radiol. 2022;40;3:229-244.
11. Jacobs M.A., Macura K.J., Zaheer A., Antonarakis E.S., Stearns V., Wolff A.C., Feiweier T, Kamel I.R., Wahl R.L., Pan L. Multiparametric Whole-Body MRI with Diffusion-Weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Acad. Radiol. 2018;25;11:1405-1414.
12. Donners R., Figueiredo I., Tunariu N., Blackledge M., Koh D.M., de la Maza MLDF, Chandran K., de Bono J.S., Fotiadis N. Multiparametric Bone MRI Can Improve CT-Guided Bone Biopsy Target Selection in Cancer Patients and Increase Diagnostic Yield and Feasibility of Next-Generation Tumour Sequencing. Eur. Radiol. 2022;32;7:4647-4656.
13. Cao J., Gao S., Zhang C., et al. Differentiating Atypical Hemangiomas and Vertebral Metastases: a Field-of-View (FOV) and FOCUS Intravoxel Incoherent Motion (IVIM) Diffusion-Weighted Imaging (DWI) Study. Eur. Spine J. 2020;29:3187–3193.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2023. Accepted for publication: 27.08.2023.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 6
DOI:10.33266/1024-6177-2023-68-6-73-79
E.I. Matkevich1, A.N. Bashkov1, E.A. Ionova1, A.U. Veselkova1,V.S. Rudakov1,
O.V. Parinov1, V.V. Kapustin2
Modern Possibilities of Imaging Diagnosis Methods in Assessing the Severity of Fatty Hepatosis in Non-Alcoholic Fatty Liver Disease (Clinical Case)
1 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
2 A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
Contact person: E.I. Matkevich, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To estimate the potential of imaging methods in the diagnosis of non-alcoholic fatty liver disease (NAFLD) based on the example of a clinical case.
Material and methods: A 42 years-old man with suspected of NAFLD, by the clinical and laboratory tests results, underwent a quantitative assessment of fatty hepatosis using radiodiagnosis imaging methods. We used US “liver protocol” with attenuation imaging technique (ATI), shear wave elastography (SWE), shear wave dispersion imaging (SWD), computed tomography (CT) with quantitative and qualitative assessment using the liver-spleen index (CTL-S); MRI with application that provides volumetric whole-liver fat fraction (FF) measurements by proton density (PDFF), on the basis of IDEAL IQ program. The morphological verification of liver biopsy was also performed.
Results: All imaging method used in this clinical case showed severe degree of fatty hepathosis, that correlated with biopsy of liver.
In repeated studies, on the background of treatment, the quantitative indicators of all imaging methods had a similar dynamics of reduction of the degree of fatty hepatosis.
Conclusion: The clinical case of verified acute steatohepatitis shows the possibilities of its diagnostics by means of the radiation modalities. We used US with ATI, SWE и SWD, CT with CTL-S, MRI with FF that demonstrated high diagnostic efficiency for determination fatty hepatosis and the possibility of its quantification. These technologies are suitable for widespread implementation into clinical practice providing good diagnostic accuracy. CT associated with higher doses of radiation is not considered to be the basic method of choice for diagnosing NAFLD, but still may provide a physician with necessary information to determine further treatment strategy.
Keywords: fatty hepathosis, ultrasound, CT, MRI, quantitative assessment
For citation: Matkevich EI, Bashkov AN, Ionova EA, Veselkova AU, Rudakov VS, Parinov OV, Kapustin VV. Modern Possibilities of Imaging Diagnosis Methods in Assessing the Severity of Fatty Hepatosis in Non-Alcoholic Fatty Liver Disease (Clinical Case). Medical Radiology and Radiation Safety. 2023;68(6):73–79. (In Russian). DOI:10.33266/1024-6177-2023-68-6-73-79
References
1. Paik J.M., Golabi P., Younossi Y., Mishra A., Younossi Z.M. Changes in the Global Burden of Chronic Liver Diseases from 2012 to 2017: the Growing Impact of NAFLD. Hepatology. 2020;72:1605-1616. DOI: 10.1002/hep.31173.
2. Bae J.S., Lee D.H., Suh K.S., Kim H., Lee K.B., Lee J.Y., et al. Noninvasive Assessment of Hepatic Steatosis Using a Pathologic Reference Standard: Comparison of CT, MRI, and USbased Techniques. Ultrasonography. 2022;41;2:344-354. DOI: 10.14366/usg.21150.
3. Corrias G., Krebs S., Eskreis-Winkler S., Ryan D., Zheng J., Capanu M., Saba L., Monti S., Fung M., Reeder S., Mannelli L. MRI Liver Fat Quantification in an Oncologic Population: the Added Value of Complex Chemical Shift-Encoded MRI. Clin. Imaging. 2018;52:193-199. doi: 10.1016/j.clinimag.2018.08.002.
4. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017. Ultraschall Med. 2017;38;04:e16-e47 DOI: 10.1055/s-0043-103952).
5. Park H.J., Kim K.W., Kwon H.J., Lee S., Kim D.W., Moon H.H., Song G.W., Lee S.G. CT-Based Visual Grading System for Assessment of Hepatic Steatosis: Diagnostic Performance and Interobserver Agreement. Hepatol Int. 2022;16;5:1075-1084. DOI: 10.1007/s12072-022-10373-0.
6. Chung J., Park H.S., Kim Y.J., Yu M.H., Park S., Jung S.I. Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population. Diagnostics (Basel). 2021;11;12:2168. DOI: 10.3390/diagnostics11122168.
7. Limanond P., Raman S.S., Lassman C., Sayre J., Ghobrial R.M., Busuttil R.W., Saab S., Lu D.S. Macrovesicular Hepatic Steatosis in Living Related Liver Donors: Correlation between CT and Histologic Findings. Radiology. 2004;230;1:276-280. DOI: 10.1148/radiol.2301021176.
8. Qayyum A., Nystrom M., Noworolski S.M., Chu P., Mohanty A., Merriman R. MRI Steatosis Grading: Development and Initial Validation of a Color Mapping System. AJR Am. J. Roentgenol. 2012;198;3:582-588. doi: 10.2214/AJR.11.6729.
9. Corrias G., Erta M., Sini M., Sardu C., Saba L., Mahmood U., Huicochea Castellanos S., Bates D., Mondanelli N., Thomsen B., Carollo G., Sawan P., Mannelli L. Comparison of Multimaterial Decomposition Fat Fraction with DECT and Proton Density Fat Fraction with IDEAL IQ MRI for Quantification of Liver Steatosis in a Population Exposed to Chemotherapy. Dose Response. 2021;19;2:1559325820984938. DOI: 10.1177/1559325820984938.
10. Bedossa P. Current Histological Classification of NAFLD: Strength and Limitations. Hepatol Int. 2013;7;Suppl 2:765-770. DOI: 10.1007/s12072-013-9446-z.
11. Moon K.M., Kim G., Baik S.K., Choi E., Kim M.Y., Kim H.A., Cho M.Y., Shin S.Y., Kim J.M., Park H.J., Kwon S.O., Eom Y.W. Ultrasonographic Scoring System Score Versus Liver Stiffness Measurement in Prediction of Cirrhosis. Clin. Mol. Hepatol. 2013;19;4:389-398. doi: 10.3350/cmh.2013.19.4.389.
12. Ferraioli G., Maiocchi L., Savietto G., Tinelli C., Nichetti M., Rondanelli M., Calliada F., Preda L., Filice C. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis. J. Ultrasound Med. 2021;40;7:1325-1332. DOI: 10.1002/jum.15512.
13. Огурцов П.П., Зыкин Б.И., Тарасова О.И. и др. Ультразвуковая сдвиговая эластометрия и ультразвуковая стеатометрия печени: Методические рекомендации // Вестник Последипломного медицинского образования. 2019. № 1. С. 137-148. [Ogurtsov P.P., Zykin B.I., Tarasova O.I., et al. Ultrasound Shear Elastometry and Ultrasound Osteometry of the Liver. Methodological Recommendations. Vestnik Poslediplomnogo Obrazovaniya v Sfere Zdravookhraneniya = Scientific and Practical Journal of Tajik Institute of Post-Graduate Education of Medical Staff. 2019;1:137-148 (In Russ.)].
14. Jang, J.K., Kim, S.Y., Yoo, I.W., et al. Diagnostic Performance of Ultrasound Attenuation Imaging for Assessing Low-Grade Hepatic Steatosis. Eur Radiol. 2022;32:2070–2077. DOI.org/10.1007/s00330-021-08269-y.
15. Sugimoto K., Moriyasu F., Oshiro H., Takeuchi H., Yoshimasu Y., Kasai Y., Itoi T. Clinical Utilization of Shear Wave Dispersion Imaging in Diffuse Liver Disease. Ultrasonography. 2020;39;1:3-10. doi: 10.14366/usg.19031.
16. Gu J., Liu S., Du S., Zhang Q., Xiao J., et al. Diagnostic Value of MRIPDFF for Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease: a Meta-Analysis. Eur. Radiol. 2019;29:3564–3573. DOI: 10.1007/s00330-019-06072-4.
17. Применение современных методов оценки фиброза и стеатоза в диагностике хронических заболеваний печени в условиях стационарных и поликлинических учреждений: Методические рекомендации МР № 108 от 2019 г. М.: 2019. [Application of Modern Methods for Assessing Fibrosis and Steatosis in the Diagnosis of Chronic Liver Diseases in Inpatient and Polyclinic Institutions. Methodological Recommendations of MR No. 108 of 2019. Moscow Publ., 2019 (In Russ.)].
18. EASL Clinical Practice Guidelines on Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis – 2021 Update. J. Hepatol. 2021;75;3:659-689. DOI:10.1016/j.jhep.2021.05.025.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2023. Accepted for publication: 27.08.2023.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 6
DOI:10.33266/1024-6177-2023-68-6-86-91
O.V. Gribova, Zh.A. Startseva, E.L. Choynzonov, V.A. Novikov, A.I. Ryabova,
V.I. Shtin
Combined Treatment of Salivary Gland Cancer Patients with the Use of High-Let Radiation
Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia
Contact person: O.V. Gribova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
The purpose: To evaluate the efficiency of combined treatment of patients with salivary gland cancer using neutron therapy.
Material and methods: The study included 130 patients with salivary gland cancer who underwent combined treatment with adjuvant neutron or standard photon radiotherapy. Neutron therapy was performed on a cyclotron U-120. The average energy of fast neutrons was 6.3 MeV.
Results: There was observed a significant decrease in the frequency of relapses in the group of patients who received a postoperative course of NT compared with the control group (21.1 % vs. 45 %, p<0.05). The five-year overall survival in the study group was 73.8±9.5 %, in the control group ‒ 43.2±9.4% (p<0.05). The value of five-year relapse-free survival in the study group was 65.6±7.5 %, in the control group ‒ 34.8±9.1 % (p<0.05). Erythema of the skin in the irradiation area (grade I) was the most frequent type of local acute radiation reaction and was observed in 60 % of patients in the study group and in 25 % of patients in the control group. The most frequent late complication in both groups of patients was skin atrophy and subcutaneous fibrosis (grade I on the RTOG/EORTC scale). In the study group, this indicator was 34.4 %, in the control group ‒ 20 % (p>0.05).
Conclusion: Thus, the study confirmed the high effectiveness of fast neutron therapy against malignant tumors of the salivary glands. Neutron therapy does not cause serious complications, encourages to increase of patients life expectancy and to decrease the number of relapses after combined treatment in comparison with standard methods of treatment.
Keywords: salivary gland cancer, neutron therapy, combined treatment, fast neutrons
For citation: Gribova OV, Startseva ZhA, Choynzonov EL, Novikov VA, Ryabova AI, Shtin VI. Combined Treatment of Salivary Gland Cancer Patients with the Use of High-Let Radiation. Medical Radiology and Radiation Safety. 2023;68(6):86–91. (In Russian). DOI:10.33266/1024-6177-2023-68-6-86-91
References
1. El-Naggar A.K. Tumours of Salivary Glands. WHO Classification of Head and Neck Tumours. Ed. El-Naggar A.K., JKC C., Grandis J.R., Takata T., Slootweg P.J. Lyon, France, WHO Press, 2017. P. 159–202.
2. Catterall M., Errington R.D. The Implications of Improved Treatment of Malignant Salivary Gland Tumors by Fast Neutron Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1987;13:1313-1318. https://doi.org/10.1016/0360-3016(87)90222-7 10.1016/0360-3016(87)90222-7.
3. Goodhead D.T. Neutrons Are Forever! Historical Perspectives. Int. J. Radiat. Biol. 2019;95;7:957-984. doi: 10.1080/09553002.2019.1569782.
4. Mardynskiy Yu.S., Sysoyev A.S., Gulidov I.A. Technological Problems of Using of Fast Neutron Research Reactors for Radiation Therapy in Patients with Malignant Tumors. Vestnik Rentgenologii I Radiologii = Journal of Radiology and Nuclear Medicine. 1997;4:26-29 (In Russ.).
5. Kandakova E.Yu., Vazhenin A.V., Kuznetsova A.I., Vazhenin I.A., Panshin G.A., Tsallanova Z.S. Results of the Combined Photon-Neutron Therapy in the Conditions of Escalation of a Dose of Neutrons Generally a Course of the Combined Photon-Neutron Therapy. Vestnik Rossiyskogo Nauchnogo Tsentra Rentgenoradiologii MZ Rossii. 2014;14-4:7 (In Russ.).
6. Velikaya V.V., Startseva Zh.A., Goldberg V.E., Popova N.O., Lisin V.A. Long-Term Treatment Outcomes after Neutron Therapy for Patients with Locally Recurrent Breast Cancer. Onkologicheskiy Zhurnal: Luchevaya Diagnostika, Luchevaya Terapiya = Journal of Oncology: Diagnostic Radiology and Radiotherap. 2019;2;1:27-32 (In Russ.). https://doi.org/10.37174/2587-7593-2019-2-1-27-32.
7. Choynzonov E.L., Lisin V.A., Gribova O.V., Novikov V.A., Startseva Zh.A. Neytronnaya Terapiya Zlokachestvennykh Novoobrazovaniy Golovy i Shei = Neutron Therapy of Head and Neck Cancer. Moscow Publ., 2021 P. 328 (In Russ.).
8. Von der Grün J., Winkelmann R., Rödel F., Balster S., Neumayer T., Ghanaati S., et al. Patterns of Care, Toxicity and Outcome in the Treatment of Salivary Gland Carcinomas: Long-Term Experience from a Tertiary Cancer Center. Eur. Arch. Otorhinolaryngol. 2021;278;11:4411-4421. doi:10.1007/s00405-021-06652-5.
9. Freitag V., Lettmaier S., Semrau S., Hecht M., Mantsopoulos K., Müller S.K., et al. High-Grade Salivary Gland Cancer: Is Surgery Followed by Radiotherapy an Adequate Treatment to Reach Tumor Control? Results from a Tertiary Referral Centre Focussing on Incidence and Management of Distant Metastases. Eur. Arch. Otorhinolaryngol. 2022;279;5:2553-2563. doi: 10.1007/s00405-021-07024-9.
10. Mahmood U., Koshy M., Goloubeva O., Suntharalingam M. Adjuvant Radiation Therapy for High-Grade and/or Locally Advanced Major Salivary Gland Tumors. Arch. Otolaryngol Head Neck. Surgery. 2011;137:1025–1030. doi: 10.1001/archoto.2011.158.
11. Terhaard C.H.J., Lubsen H., Van der Tweel I., Hilgers F.J.M., Eijkenboom W.M.H., Marres H.A.M., et al. Salivary Gland Carcinoma: Independent Prognostic Factors for Locoregional Control, Distant Metastases, and Overall Survival: Results of the Dutch Head and Neck Oncology Cooperative Group. Head Neck. 2004;26:681–693. doi: 10.1002/hed.10400.
12. Safdieh J., Givi B., Osborn V., Lederman A., Schwartz D., Schreiber D. Impact of Adjuvant Radiotherapy for Malignant Salivary Gland Tumors. Otolaryngol Head Neck Surg. 2017;157:988-994. https://doi.org/10.1177/0194599817717661 10.1177/0194599817717661.
13. Lee A., Givi B., Osborn V.W., Schwartz D., Schreiber D. Patterns of Care and Survival of Adjuvant Radiation for Major Salivary Adenoid Cystic Carcinoma. Laryngoscope. 2017;127:2057-2062. https://doi.org/10.1002/lary.26516 10.1002/lary.26516.
14. Jang J.Y., Choi N., Ko Y.H., Chung M.K., Son Y.I., Baek C.H., et al. Treatment Outcomes in Metastatic and Localized High-Grade Salivary Gland Cancer: High Chance of Cure with Surgery and Post-Operative Radiation in T1-2 N0 High-Grade Salivary Gland Cancer. BMC Cancer. 2018;18;1:672. doi: 10.1186/s12885-018-4578-0.
15. Cheraghlou S., Kuo P., Mehra S., Agogo G.O., Bhatia A., Husain Z.A., et al. Adjuvant Therapy in Major Salivary Gland Cancers: Analysis of 8580 Patients in the National Cancer Database. Head Neck. 2018;40;7:1343-1355. doi: 10.1002/hed.24984.
16. Meyers M., Granger B., Herman P., Janot F., Garrel R., Fakhry N., et al. Head and Neck Adenoid Cystic Carcinoma: a Prospective Multicenter Refcor Study of 95 Cases. Eur. Ann. Otorhinolaryngol Head Neck Dis. 2016;133;1:13-17. doi: 10.1016/j.anorl.2015.09.009.
17. Kokemueller H., Eckardt A., Brachvogel P., Hausamen J.E. Adenoid Cystic Carcinoma of the Head and Neck--a 20 Years Experience. Int. J. Oral. Maxillofac Surg. 2004;33;1:25-31. doi: 10.1054/ijom.2003.0448.
18. Lindsley K.L., Cho P., Stelzer K.J., et al. Clinical Trials of Neutron Radiotherapy in the United States. Bull. Cancer Radiother. 1996;83Suppl:78s-86s. https://doi.org/10.1016/0924-4212(96)84889-4 10.1016/0924-4212(96)84889-4.
19. Huber P.E., Debus J., Latz D., et al. Radiotherapy for Advanced Adenoid Cystic Carcinoma: Neutrons, Photons or Mixed Beam? Radiother Oncol. 2001;59:161-167. https://doi.org/10.1016/s0167-8140(00)00273-5 10.1016/s0167-8140(00)00273-5.
20. Davis C., Sikes J., Namaranian P., Laramore G., Dillon J.K. Neutron Beam Radiation Therapy: an Overview of Treatment and Oral Complications when Treating Salivary Gland Malignancies. J. Oral. Maxillofac Surg. 2016;74:830-835. https://doi.org/10.1016/j.joms.2015.10.014 10.1016/j.joms.2015.10.014.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2023. Accepted for publication: 27.08.2023.